19 / 48
19
Symposia
/ Preliminary Scientific Programme
WFSBP 2017
S-07-004
Neurobiological correlates of the treatment of emotion
processing in schizophrenia
Gabriele Sachs, Austria
T19: INFLAMMATION PSYCHIATRY
S-08
12:30–14:00
Inflammation markers of peripherial blood in
depression spectrum
Chair:
Piotr Galecki, Poland
Co-Chair: Angelos Halaris, USA
S-08-001
(Auto)immune biomarkers of depression and subtypes
Michael Maes, Thailand
S-08-002
Targeting inflammation to prevent depression
Michael Berk, Australia
S-08-003
Stratification of depressed patients by means of
blood markers of inflammation, growth factors and
kynurenine metabolites
Angelos Halaris, USA
S-08-004
Omega-3 fatty acids, inflammation and depression:
From biological mechanisms to clinical application
Kuan-Pin Su, Taiwan
T39: PSYCHONEUROIMMUNOLOGY
S-09
14:30–16:00
Mechanisms contributing to neuroprogression in
psychiatric disorders and promising interventions
Chair:
Angelos Halaris, USA
S-09-001
Inflammatory and innate immune markers of neuropro-
gression in depressed and teenage suicide brain
Ghanshyam Pandey, USA
S-09-002
Major depression as a prelude to dementia: What is the
evidence?
Brian Leonard, Ireland
S-09-003
Neuroimaging of microglia activation in major depression
Jeffrey Meyer, Canada
S-09-004
Promising neuroprotective and anti-inflammatory inter-
ventions to arrest neuroprogression
Angelos Halaris, USA
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-10
14:30–16:00
Effects and side effects of electroconvulsive therapy
Chair:
Michael Grözinger, Germany
Co-Chair: Helge Frieling, Germany
S-10-001
Effects of ECT on the oxygen saturation in the frontal brain
Michael Grözinger, Germany
S-10-002
DNA methylation of P11/S100A10: A putative marker of
response to ECT?
Helge Frieling, Germany
S-10-003
Electroconvulsive therapy enhances amyloid ß 1-42 in
the cerebrospinal fluid of patients with major depression
Alexander Sartorius, Germany
S-10-004
The EFFECT-Dep Trial (ISRCTN23577151): Immediate
and long-term cognitive outcomes
Declan McLoughlin, Ireland
T43: SCHIZOPHRENIA: BASIC/CLINICAL
S-11
14:30–16:00
Abnormal neurogenesis in schizophrenia
Chair:
Dragos Inta, Germany
Co-Chair: Guo-Li Ming, USA
S-11-001
Modeling predisposition to schizophrenia using hiPSCs
Kristen Brennand, USA
S-11-002
Neurogenesis and psychiatric neurodevelopmental
disorders
Guo-Li Ming, USA
S-11-003
Precise activation of the Reelin pathway controls den-
dritic maturation, synapse formation and glial ensheath-
ment of adult-generated granule cells
Eduardo Soriano, Spain
SUN